Dow Down 0.36% Nasdaq Down 0.53%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
14.52 Down 0.39(2.62%) Sep 12, 4:00PM EDT
Prev Close:14.91
Open:14.91
Bid:13.90 x 100
Ask:15.95 x 100
1y Target Est:31.17
Beta:-0.64
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:14.38 - 14.95
52wk Range:12.61 - 29.79
Volume:1,376,582
Avg Vol (3m):499,586
Market Cap:335.54M
P/E (ttm):N/A
EPS (ttm):-1.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RPRX

Comparison

Symbol% ChgMkt Cap
RPRXDown 2.62%335.54M
ABTDown 0.02%63.98B
ACTUp 0.70%61.94B
AUXLDown 1.92%1.13B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.53
Quarterly EPS Est (Sep-14) :-0.39
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.31

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback